Last update :
17/04/2024
Anticancer drug   Vinorelbine tartrate  
Injection
Stability in solutions Stability of mixtures Factors which affect stability Compatibility Route of administration References Pdf
   Chemical structure  

Tradename   Tradename     

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Eberelbin Iran
Eunexon Peru
Eurovinorelbin Germany
Navelbin Hungary
Navelbine Argentina, Australia, Austria, Belgium, Chile, Colombia, Denmark, Egypt, Finland, France, Germany, Great Britain, Greece, Iceland, India, Iran, Ireland, Italy, Luxembourg, Malaysia, Mexico, New Zealand, Norway, Peru, Poland, Portugal, Romania, Saudi Arabia, Spain, Sweden, Switzerland, Tunisia, Turkey, United Arab Emirates, United States of America
Navildez Mexico
Navin Germany
Navirel Germany, Norway, Sweden
Okabine Peru
Relbinalur Sweden
Renovel Turkey
Setroxin Mexico
Sulcoline Argentina
Tarckorel Mexico, Peru
Vieby Mexico
Viessia Colombia, Mexico, Venezuela
Vilne Argentina, Ecuador, Peru
Vinarine Argentina, Peru, Venezuela
Vinelbine Malaysia
Vinilex Mexico
Vinkebir Argentina, Peru
Vinobina Colombia
Vinobur Sweden
Vinolbin Germany
Vinorel Argentina, Peru
Vinorelbin Austria, Belgium, Ecuador, Germany, Iceland, Norway, Romania, Sweden, Switzerland
Vinorelbina Colombia, Ecuador, Mexico, Peru, Romania, Spain
Vinorelbine Argentina, Belgium, Canada, Great Britain, Iran, New Zealand, Switzerland, United States of America
Vinorgen Chile, Peru
Zinavin Colombia
Stability in solutions   Injection   Stability in solutions : Vinorelbine tartrate     
Container Solvent Concentration Temperature Storage Duration of stability References
Glass NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 2-8°C Protect from light
28 Day
2260
Manufacturer's stability data

Glass NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 25°C Protect from light
28 Day
2260
Manufacturer's stability data

Glass NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 25°C Light
4 Day
2260
Manufacturer's stability data

Glass Sodium chloride 0,9% 0,385 mg/ml 23°C Protect from light
7 Day
1501
Level of evidence A

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0,5 & 2 mg/ml 23-25°C Light
5 Day
1413
Level of evidence D

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 2-8°C Protect from light
28 Day
2260
Manufacturer's stability data

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 25°C Protect from light
28 Day
2260
Manufacturer's stability data

Polyvinyl chloride NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 25°C Light
4 Day
2260
Manufacturer's stability data

Polyvinyl chloride Sodium chloride 0,9% 0,385 mg/ml 23°C Protect from light
7 Day
1501
Level of evidence A

Polyvinyl chloride Sodium chloride 0,9% 0,5 mg/ml 4°C Protect from light
3 Day
144
Level of evidence D

Polyvinyl chloride Glucose 5% 0,5 mg/ml 4°C Protect from light
7 Day
144
Level of evidence D

Polyethylene NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 2-8°C Protect from light
28 Day
2260
Manufacturer's stability data

Polyethylene NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 25°C Protect from light
28 Day
2260
Manufacturer's stability data

Polyethylene NaCl 0,9% or Glucose 5% 0.5 & 3 mg/ml 25°C Light
4 Day
2260
Manufacturer's stability data

Polyethylene Sodium chloride 0,9% 0,385 mg/ml 21°C Not specified
7 Day
1520
Manufacturer's stability data

Polyethylene Sodium chloride 0,9% 0,385 mg/ml 23°C Protect from light
7 Day
1501
Level of evidence A


  Mentions Légales